Longevity Ensured Automatically and Painlessly

Longevity Research

Funding Aging Research

How to Automatically and Painlessly Help Ensure Your Longevity

posted on Novemeber 03, 2009

When I lived in a small Pennsylvania town, I held fundraisers for medical research. I raised more funds when the donors got a tangible value in return. For example, I held oldies dances and filled the arena. How? For less than $20, donors would be treated to four and a half hours of great music from four different bands, dancing, FREE beer, wine, soda and snacks, as well as get chances on door prizes.

Believe it or not, the economics made sense when you sell almost 2000 tickets. And volunteers and sponsors (who got great media coverage) helped the bottom line as well.

In fact, one of the events paid for our first international longevity brainstorm session. Go to www.ManhattanBeachProject, to see what we leveraged that into.

The lesson of gaining by giving more than you receive stayed with me.

So now I have an irresistible offer for you that could result in a steady income stream for Maximum Life Foundation. And it won™t cost you $20. In fact, it won™t cost you a dime. Better yet, you can actually save money by doing exactly what you do already. And best of all, you may even get a monthly check.

When I first heard about this, I thought, œOh no, not another network marketing scheme. But after I explored it, it seemed to be a no-lose, no-brainer way to raise research money.

Here™s all you need to do.

Simply sign up at a new website called Blastoff, which is a portal to hundreds of retailers. Just go to this page:


By using Blastoff to buy online, you™ll get money back every time you make a purchase. They send you a rebate check once a month - and even better, if you invite friends they will all be part of your network, so you™ll also receive cash back every time they purchase something! But here's the MaxLife connection: when you or your friends sign up through the above link, you and they will be part of the MaxLife network, and that means MaxLife will also receive a monthly payment!

So, please click on the link above. It™s free, and it takes just 20 seconds.

Maximum Life Foundation raises money in this exceptionally painless way, for the research that will hopefully keep us all young and healthy for a long time to come. This is a great opportunity to help contribute to longevity research without any cost to you. Again: please go to:


Please do this today, and also encourage your friends to do the same, because the site goes public today, and the number of organizations attracting donations will explode from then on.

Thanks so much in advance!

Best, Dave


Our immune systems can destroy cancer - but the immune system grows less effective with age, and sometimes it fails in this task. That "sometimes" is enough to kill a quarter of humanity, the fraction of us who die from cancer. Researchers are closing in on the mechanisms that separate success from failure, however, and in the years ahead will be able to tune our immune systems to destroy cancer nearly 100% of the time: "A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors. The role of Th17, one of only four known types of T helper cell, opens a possible avenue for overcoming cancer's ability to suppress or hide from the body's immune system. While there is much work to be done, these preclinical findings imply the possibility of taking a patient's Th17 cells, expanding them in the lab, and then re-infusing them as treatment. Development of a vaccine to stimulate Th17 cells would be another possible application."

PROSPECTS FOR BRAIN REGENERATIVE MEDICINE (October 29 2009) http://www.longevitymeme.org/news/vnl.cfm?id=4442
Will it be possible to use patient-derived cell transplants to heal the brain in much the same way as can be done with other organs? From EurekAlert!: researchers have "found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function. We aimed at determining whether autografted cells derived from cortical gray matter, cultured for one month and re-implanted in the caudate nucleus of dopamine depleted primates, effectively survived and migrated. The autologous, re-implanted cells survived at an impressively high rate of 50 percent for four months post-implantation ... Researchers found that the cultured cells migrated, re-implanted into the right caudate nucleus, and migrated through the corpus callosum to the contralateral striatum. Most of the cells were found in the most dopamine depleted region of the caudate nucleus. This study replicated in primates the success the research team had previously reported using laboratory mice."

ON PRESENTING THE CASE FOR LONGEVITY SCIENCE (October 26 2009) http://www.longevitymeme.org/news/vnl.cfm?id=4437
Opinions from a bioethicist on how researchers should present the case for longevity science in order to maximize fundraising and public support: "The medical sciences are currently dominated by the 'disease-model' approach to health extension, an approach that prioritizes the study of pathological mechanisms with the goal of discovering treatment modalities for specific diseases. This approach has marginalized research on the aging process itself, research that could lead to an intervention that retards aging, thus conferring health dividends that would far exceed what could be expected by eliminating any specific disease of aging. This paper offers a diagnosis of how this sub-optimal approach to health extension arose and some general prescriptions concerning how progress could be made in terms of adopting a more rational approach to health extension. Drawing on empirical findings from psychology and economics, 'prospect theory' is applied to the challenges of 'framing' the inborn aging process given the cognitive capacities of real (rather than rational) decision-makers under conditions of risk and uncertainty. Prospect theory reveals that preferences are in fact dependent on whether particular outcomes of a choice are regarded as 'a loss' or 'a gain', relative to a reference point (or 'aspiration level for survival'). And this has significant consequences for the way biogerontologists ought to characterise the central aspirations of the field (i.e. to prevent disease versus extend lifespan)." Personally, I'm more in favor of entirely the opposite approach - don't adapt your argument to the suboptimal cultural environment, but rather work to change that cultural environment.

A LOOK AT THE STATE OF TISSUE SCAFFOLDING (October 26 2009) http://www.longevitymeme.org/news/vnl.cfm?id=4436

Progress continues in the development of biochemically active scaffolding to sculpt and guide tissue regeneration: here, ScienceDaily looks at a scaffold "made from soluble fibers, which may help humans replace lost or missing bone. With more research, [it] could also serve as the basic technology for regenerating other types of human tissues, including muscle, arteries, and skin. The bioactive agents that spur bone and tissue to regenerate are available to us. The problem is that no technology has been able to effectively deliver them to the tissue surrounding that missing bone. [This] artificial and flexible scaffolding connects tissues together as it releases growth-stimulating drugs to the place where new bone or tissue is needed - like the scaffolding that surrounds an existing building when additions to that building are made. The [scaffold material] could be used to restore missing bone in a limb lost in an accident, or repair receded jawbones necessary to secure dental implants. The scaffold can be shaped so the bone will grow into the proper form. After a period of time, the fibers can be programmed to dissolve, leaving no trace."

Back to Top